Helical Platform Now Available on AWS Agentic Marketplace

Luxembourg, Luxembourg – July 16th, 2025 – Helical, a leading provider of AI-powered in-silico experimentation platforms for drug discovery, today announced the availability of the Helical Platform in the new AI Agents and Tools category of AWS Marketplace.
‍

Customers can now use AWS Marketplace to easily discover, buy, and deploy AI agent solutions — including Helical’s platform — directly through their AWS accounts. This launch accelerates agent and agentic workflow development in pharma and biotech by streamlining procurement and deployment.
‍

Helical Platform helps organizations run in-silico experiments powered by Bio Foundation Models, enabling customers to unlock drug discovery use cases such as target identification, biomarker discovery, and patient stratification.
‍

"By offering Helical’s Platform in the AWS Marketplace we're providing customers with a streamlined way to access our AI in-silico labs, helping them buy and deploy agent solutions faster and more efficiently."

— Rick Schneider, CEO at Helical

"Our customers in pharmaceutical and biotech companies are already using these capabilities to identify novel targets, discover biomarkers, and simulate drug responses — demonstrating the real-world value of AI-powered drug discovery."
‍

The Helical Platform delivers essential capabilities including:

• Personalized Bio Foundation Models
• Scalable in-silico experimentation
• Seamless data integration

These features enable R&D teams to accelerate target discovery, reduce wet-lab iteration cycles, and bring therapies to market faster.
‍

With the launch of the AI Agents and Tools category in AWS Marketplace, customers benefit from:

• Centralized purchasing through AWS accounts
• Simplified licensing and procurement workflows
• Enhanced visibility and control over access and spend
  ‍

Learn More

• Explore Helical on AWS Marketplace

• Explore the new AI Agents and Tools category

About Helical

Helical is the in-silico AI lab for pharma, powered by Bio Foundation Models. The model-agnostic platform enables pharma and biotech teams to run scalable, reproducible in-silico experiments for target discovery, biomarker development, patient stratification, and RNA therapy design.

Helical abstracts away AI and infrastructure complexity so teams can personalize foundation models, simulate biological perturbations, and accelerate research across therapeutic areas at scale.

‍